A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Exclusion Criteria

• •AST and/or ALT \> 3 times ULN
• •Serum total bilirubin \> 2 mg/dL
• •Serum creatinine ≥ 1.50 mg/dL for men or ≥ 1.40 mg/dL for women
• •Creatine kinase ≥ 3 times ULN
• •Symptoms of severely uncontrolled diabetes
• •Currently unstable or serious cardiovascular, renal, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases